These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9677398)

  • 1. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding.
    Hobba GD; Löthgren A; Holmberg E; Forbes BE; Francis GL; Wallace JC
    J Biol Chem; 1998 Jul; 273(31):19691-8. PubMed ID: 9677398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction.
    Moss JA; Francis GL; Ross M; Wallace JC; Ballard FJ
    J Biol Chem; 1991 Jan; 266(2):909-14. PubMed ID: 1702441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination.
    Hobba GD; Forbes BE; Parkinson EJ; Francis GL; Wallace JC
    J Biol Chem; 1996 Nov; 271(48):30529-36. PubMed ID: 8940022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biological characterization of bovine insulin-like growth factor binding protein-3.
    Conover CA; Ronk M; Lombana F; Powell DR
    Endocrinology; 1990 Dec; 127(6):2795-803. PubMed ID: 1701128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains.
    Carrick FE; Forbes BE; Wallace JC
    J Biol Chem; 2001 Jul; 276(29):27120-8. PubMed ID: 11356837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain.
    Forbes BE; Turner D; Hodge SJ; McNeil KA; Forsberg G; Wallace JC
    J Biol Chem; 1998 Feb; 273(8):4647-52. PubMed ID: 9468524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
    Dong F; Wu HB; Hong J; Rechler MM
    J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins.
    Wong MS; Fong CC; Yang M
    Biochim Biophys Acta; 1999 Jul; 1432(2):293-301. PubMed ID: 10407151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M; Uhlen M; Nilsson B
    Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
    Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
    Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I and its binding proteins: a study of the binding interface using B-domain analogues.
    Magee BA; Shooter GK; Wallace JC; Francis GL
    Biochemistry; 1999 Nov; 38(48):15863-70. PubMed ID: 10625451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.
    Shand JH; Beattie J; Song H; Phillips K; Kelly SM; Flint DJ; Allan GJ
    J Biol Chem; 2003 May; 278(20):17859-66. PubMed ID: 12626499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
    Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
    Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
    Dubaquié Y; Lowman HB
    Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis.
    Jansson M; Andersson G; Uhlén M; Nilsson B; Kördel J
    J Biol Chem; 1998 Sep; 273(38):24701-7. PubMed ID: 9733769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).
    Fottner C; Engelhardt D; Weber MM
    Horm Metab Res; 1999; 31(2-3):203-8. PubMed ID: 10226803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
    Bond JJ; Meka S; Baxter RC
    J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.
    Bramani S; Song H; Beattie J; Tonner E; Flint DJ; Allan GJ
    J Mol Endocrinol; 1999 Aug; 23(1):117-23. PubMed ID: 10425523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.